Schonfeld Strategic Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 11,750 shares of AMPH stock, worth $591,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,750

Previous 6,229 88.63%

Holding current value

$591,847

Previous $273,000 72.16%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $213,386 - $240,053	5,521 Added 88.63%	11,750 $470,000
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $266,912 - $395,230	6,229 New	6,229 $273,000
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $460,900 - $516,017	-16,502 Reduced 50.16%	16,398 $459,000
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $691,756 - $947,525	25,100 Added 321.79%	32,900 $924,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $437,913 - $621,663	-14,700 Reduced 65.33%	7,800 $271,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $516,600 - $820,125	22,500 New	22,500 $807,000
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $888,466 - $1.41 Million	-70,179 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $1.2 Million - $1.45 Million	70,179 New	70,179 $1.35 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $22.62 $325,040 - $384,540	-17,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $501,380 - $608,440	-26,500 Reduced 60.92%	17,000 $358,000
Q1 2019 May 15, 2019	BUY	$19.46 - $25.28 $846,510 - $1.1 Million	43,500 New	43,500 $888,000

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

34.3M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.47B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History